Abstract:The aggregation of amyloid-β peptides (Aβ) is considered as one of the mainly possible causes of the Alzheimer's diseases (AD). How to suppress the formation of toxic Aβ aggregates has been intensively concerned over the past several decades. Increasing evidence shows that whether carbon nano-materials could suppress or promote the aggregation depend on their physicochemical properties. However, as amyloid fibrillization is a complex process, their interaction dynamics remains elusive. In this presentation, we have investigated the interaction between Aβ(16-22) peptides/full-length Aβ peptides and three kinds of carbon nanomaterials (carbon nanotube, fullerene, and graphene) by utilizing atomic force microscopy (AFM), electrostatic force microscopy (EFM), Thioflavin T (ThT) fluorescence, combined with molecular dynamic (MD) simulations. Our experimental results demonstrate that all of the three carbon nano-materials could suppress the process of Aβ fibrillation. EFM and ThT fluorescence results further confirmed that the Aβ peptides are strongly absorbed on the surface of carbon nano-materials by forming non-fibrillar aggregates. At the molecular scale, it is found that carbon nano-materials dramatically inhibit the formation of ordered β-sheet-rich structures as the strong hydrophobic and aromatic stacking interactions between carbon nano-materials and Aβ peptides. In comparison, the fullerenes exhibit the most excellent inhibitory ability by the strong aromatic stacking of the fullerene hexagonal rings with the Phe rings, as well as the outstanding biocompatibility. Furthermore, we found that the bare carbon nanotube could dissociate the preformed fibrils to some extent. Our results provide novel clues for studying interaction in amyloid/carbon-material system and seeking amyloidosis inhibitors with carbon nanomaterials, which may have important potentials in the development of drug candidates against Alzheimer's disease.

Phosphorylation of Covalent Organic Frameworks Nanospheres for Inhibition of Amyloid-β Peptide Fibrillation

Studies of the Interaction Between Aβ Peptides and Carbon Nano-Materials

Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

Advanced Nanomaterials for Modulating Alzheimer's Related Amyloid Aggregation

Curved carbon photo-oxygenation catalysts for the suppression and nanoscopic imaging of β-amyloid peptides fibrillation

Inhibition of Aβ Aggregation and Tau Phosphorylation with Functionalized Biomimetic Nanoparticles for Synergic Alzheimer's Disease Therapy

Nanomaterials for Modulating the Aggregation of -Amyloid Peptides

The Molecular Mechanism of Fullerene-Inhibited Aggregation of Alzheimer's Β-Amyloid Peptide Fragment

Biomimetic engineering of a neuroinflammation-targeted MOF nanozyme scaffolded with photo-trigger released CO for the treatment of Alzheimer's disease

Porous organic cage as an inhibitor of Aβ42 peptide: a simulation study

Nanomaterials for Modulating the Aggregation of β-Amyloid Peptides

Metal-Organic Frameworks Harness Cu Chelating and Photooxidation Against Amyloid β Aggregation in Vivo

Charged Tubular Supramolecule Boosting Multivalent Interactions for the Drastic Suppression of Aβ Fibrillation

Co-Assembled Nanoparticles toward Multi-Target Combinational Therapy of Alzheimer's Disease by Making Full Use of Molecular Recognition and Self-Assembly

Porous Organic Cages As Inhibitors of Aβ42 Peptide Aggregation: a Simulation Study.

Coassembly of Macrocyclic Amphiphiles for Anti-beta-Amyloid Therapy of Alzheimer's Disease

Self‐Assembled Peptide–Polyoxometalate Hybrid Nanospheres: Two in One Enhances Targeted Inhibition of Amyloid Β‐peptide Aggregation Associated with Alzheimer's Disease

Charged Tubular Supramolecule Boosting Multivalent Interactions for the Drastic Suppression of A beta Fibrillation

Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro

Inhibition of Amyloid Peptide Fibrillation by Inorganic Nanoparticles: Functional Similarities with Proteins